There are 702 resources available
Q&A and discussion
Session: Mini Oral session 2
Resources:
Webcast
The radiation oncologist’s perspective
Presenter: Pierfrancesco Franco
Session: ESO session: ESO observatory: Forecast for colorectal cancer in the next 12 months
Resources:
Slides
Webcast
Neoadjuvant botensilimab (BOT) plus balstilimab (BAL) in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial
Presenter: Mehraneh Dorna Jafari
Session: Mini Oral Session 2
Resources:
Slides
Webcast
7MO - Combined analyses of ctDNA and Immunoscore in stage III colon cancer patients: A post hoc analysis of the IDEA-France and -Greece trials
Presenter: Julien Taieb
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
The nurse’s perspective
Presenter: Tihana Batrnek
Session: ESO session: ESO observatory: Forecast for colorectal cancer in the next 12 months
Resources:
Slides
Webcast
Neoadjuvant nivolumab plus ipilimumab in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) rectal tumors: ECOG-ACRIN EA2201
Presenter: Kristen Ciombor
Session: Mini Oral Session 2
Resources:
Slides
Webcast
8MO - Neoadjuvant botensilimab (BOT) plus balstilimab (BAL) in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial
Presenter: Mehraneh Dorna Jafari
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
The patient advocate’s perspective
Presenter: Zorana Maravic
Session: ESO session: ESO observatory: Forecast for colorectal cancer in the next 12 months
Resources:
Slides
Webcast
Invited discussant abstracts 7MO, 8MO and 242MO
Presenter: Juan Manuel Ramon O'Connor
Session: Mini Oral Session 2
Resources:
Slides
Webcast
242MO - Neoadjuvant nivolumab plus ipilimumab in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) rectal tumors: ECOG-ACRIN EA2201
Presenter: Kristen Ciombor
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast